We are live on
!
Find out more
SN
Sittner & Nelson Portfolio holdings
AUM
$274M
1-Year Est. Return
22.46%
This Fund
S&P 500
This Quarter
Est. Return
+2.08%
1 Year Est. Return
+22.46%
3 Year Est. Return
+78.95%
5 Year Est. Return
+110.07%
10 Year Est. Return
–
AUM
$231M
AUM Growth
+$7.09M
(+3.2%)
Cap. Flow
+$4.92M
Cap. Flow
% of AUM
2.13%
Top 10 Holdings %
Top 10 Hldgs %
48.94%
Holding
507
New
77
Increased
115
Reduced
52
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$1.7M |
| 2 |
Capital Group Core Equity ETF
CGUS
|
+$793K |
| 3 |
ASML
ASML
|
+$560K |
| 4 |
Capital Group Dividend Value ETF
CGDV
|
+$546K |
| 5 |
Seagate
STX
|
+$479K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$307K |
| 2 |
MPT
Medical Properties Trust
MPT
|
+$234K |
| 3 |
JPMorgan Chase
JPM
|
+$217K |
| 4 |
Sunoco
SUN
|
+$215K |
| 5 |
GSK
GSK
|
+$187K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.39% |
| 2 | Financials | 18.7% |
| 3 | Healthcare | 9.25% |
| 4 | Industrials | 7.71% |
| 5 | Consumer Discretionary | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLNA
501
Filana Therapeutics
FLNA
$48.8M
| – | – |
-2,800
| Closed | -$82.4K |
|
502
Super Micro Computer
SMCI
$18.2B
| – | – |
-50
| Closed | -$2.08K |
|
503
Sanofi
SNY
$104B
| – | – |
-2,000
| Closed | -$115K |
|
|
504
Sunoco
SUN
$14.4B
| – | – |
-4,000
| Closed | -$215K |
|
505
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
| – | – |
-114
| Closed | -$7.18K |
|
|
BXRX
506
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
| $0 | ﹤0.01% |
1
| – | – |
|
|
SIVB
507
DELISTED
SVB Financial Group
SIVB
| – | – |
-10
| Closed | – |
|
Similar funds
MC
OL
JWM
MP
SCM
3C
ACM
AGP
Sittner & Nelson's Q4 2024 Portfolio in Review
As of Q4 2024, Sittner & Nelson held 507 positions worth $231M, up 3.2% from $224M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Sittner & Nelson's Q4 2024 filing shows 77 new, 115 increased, 52 reduced and 15 closed positions. Its largest new stake was MAG Silver: 5,000 shares worth $68K. The largest sale was Pfizer, an estimated $307K.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- Sittner & Nelson's largest Q4 2024 buy was MAG Silver: 5,000 shares worth $68K.
- Sittner & Nelson added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q4 2024, an estimated $1.7M increase.
- Sittner & Nelson's biggest Q4 2024 reduction was Pfizer, cutting an estimated $307K.
- Sittner & Nelson fully exited Medical Properties Trust in Q4 2024, selling an estimated $234K.
- Sittner & Nelson's ten largest holdings make up 49% of its $231M portfolio in Q4 2024.
- Sittner & Nelson opened 77 new positions and closed 15 in Q4 2024.
- Sittner & Nelson's portfolio value rose 3.2% quarter-over-quarter to $231M.
Based on Sittner & Nelson's 13F filing for Q4 2024, filed 11 Feb 2025.